Call for Papers: Advancing Excellence in Hematology and Oncology

A premier global forum for transformative research in blood disorders and cancer therapeutics.

The Journal of Hematology and Oncology Research (JHOR) is at the forefront of disseminating peer-reviewed findings that shape the future of cancer care and hematological medicine. JHOR remains committed to providing a robust, open-access platform for the global scientific community. We seek manuscripts that provide clinical context and therapeutic promise.

Our mission is to foster a rigorous environment where ideas from Gynecologic Oncology, Radiation Oncology, and beyond converge to improve patient outcomes. By publishing with JHOR, you ensure your research reaches a diverse audience of practitioners and scientists worldwide.

ISSN: 2372-6601

JHOR is currently prioritizing submissions across several key domains. We encourage studies integrating genomic data and clinical trials.

• Original Research: Full-length reports of primary studies with significantFindings.
• Review Articles: Assessments of existing literature providing new syntheses.
• Systematic Reviews: Summaries adhering to international standards.
• Short Communications: Reports of high-impact preliminary data for rapid dissemination.
• Methods & Protocols: Descriptions of laboratory techniques or protocols.
• Case Reports: Unique clinical presentations providing educational value.
• Perspectives: Pieces discussing future directions or ethical debates.

Communication in oncology requires clarity and accountability. Authors must ensure their work follows these standards:

• Informed Consent: Clinical research must state informed consent was obtained and approved by an ethics committee.
• Animal Welfare: Research involving animal models must comply with the 3Rs (Replace, Reduce, Refine).
• Reporting Guidelines: We encourage the use of EQUATOR Network guidelines (e.g., CONSORT, STROBE).
• Conflict of Interest: Authors are required to disclose any financial or personal relationships.
• Data Transparency: JHOR supports open data. Authors are encouraged to provide a Data Availability Statement.

As an independent publisher, JHOR relies on APCs to maintain editorial excellence. APCs are only assessed upon successful acceptance. This investment supports hosting, DOI assignment, and broad dissemination.

Waivers: Financial constraints should not hinder quality science. JHOR offers waivers for authors from low-income countries. For details, visit our APC Information Page.

Building a future where hematology and oncology knowledge is accessible to all. Last updated: January 2026.